{"id":6467,"date":"2016-09-02T12:34:41","date_gmt":"2016-09-02T16:34:41","guid":{"rendered":"http:\/\/sites.bu.edu\/urbanarch\/?page_id=6467"},"modified":"2016-12-22T11:06:45","modified_gmt":"2016-12-22T16:06:45","slug":"urban-arch-newsletter-10","status":"publish","type":"page","link":"https:\/\/sites.bu.edu\/urbanarch\/urban-arch-newsletter-10\/","title":{"rendered":"URBAN ARCH Newsletter"},"content":{"rendered":"

URBAN ARCH Newsletter<\/h1>\n

Volume 3, Issue 3<\/span><\/h3>\n

July\u00a02016 – September\u00a02016<\/span><\/h3>\n
\n

Check out the current issue of URBAN ARCH News, the quarterly newsletter bringing you news based on the latest URBAN ARCH and related research.<\/span><\/h1>\n
\n

URBAN ARCH 2.0 – The Cores and Cohorts are Renewed for 5 More Years!<\/strong><\/span><\/span><\/p>\n

\"URBAN<\/a><\/p>\n

l-r: URBAN ARCH PIs at the 2016 Annual Meeting (Judy Hahn, Rich Saitz, Debbie Cheng, Jeffrey Samet, and Matt Freiberg)<\/em><\/span><\/p>\n

This time five years ago, URBAN ARCH was just forming as an NIAAA HIV-alcohol consortium. After many meetings, analyses, awards, papers, and presentations, we now look ahead to an additional five years of URBAN ARCH research. The URBAN ARCH Consortium was awarded $12.3 million in renewal funding from NIAAA to investigate HIV-associated comorbidities, co-infections, and complications in the context of alcohol use. Building on the existing relationships and infrastructure, the study teams and cores are in an excellent position to begin research activities and launch the studies. Uganda ARCH (PI: Hahn) will generate data on the safety and tolerability of TB preventive therapy for HIV-infected drinkers as well as HIV-infected drinkers\u2019 level of adherence to 3- and 6-month TB regimens. Russia ARCH (PIs: Samet, Freiberg, Tindle) will initiate an RCT among HIV-infected persons with heavy alcohol consumption who also smoke to compare the effects of varenicline, cytistine, and nicotine replacement therapy to reduce alcohol use, smoking, and risk for cardiovascular disease. Finally, Boston ARCH (PI: Saitz) will test the associations between alcohol (and illicit drugs and polypharmacy), falls, and fractures and whether frailty mediates these associations in people living with HIV infection, and develop and pilot test the feasibility of a falls prevention intervention.<\/span><\/p>\n

You can learn more about each renewal study here<\/a>.<\/span><\/p>\n

\n

In the News<\/a><\/a><\/span><\/span><\/strong><\/span><\/p>\n